Lost in translation: study probes language barriers in gynecologic cancer care
NCT ID NCT05971303
First seen Jun 25, 2026 · Last updated Sep 18, 2026 · Updated 2 times
Summary
This study gives questionnaires to patients, interpreters, and healthcare professionals to understand how language and cultural differences impact care for women with gynecologic cancer. The goal is to identify barriers and improve the patient experience. About 45 people will take part at a single cancer center in Toronto.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal specific barriers faced by non-English-speaking patients with gynecologic cancer, pointing toward better communication and support strategies.
- What could go wrong
- This is a small, observational questionnaire study at a single center. It does not test a treatment, so findings may not apply broadly or lead directly to changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
45 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients, interpreters and cancer care professionals involved in the care of oncology patients with gynecologic malignancies with culturally and linguistically diverse (CALD) backgrounds.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Patient Questionnaires: Inclusion Criteria: * Patients who have received anti-cancer treatment and continue to be followed up at Princess Margaret Cancer Centre for a confirmed gynecologic malignancy. * Patients who have received anti-cancer treatment and continue to be followed up at Princess Margaret Cancer Centre for a confirmed gynecologic malignancy. * Patients self-identify their preferred spoken and/or written language to be a language other than English. * The patient's self-identified preferred language is one of the languages in which the questionnaire has been translated. * Patients must be \>18 years old. * Patients must be willing and able to complete a questionnaire (in their primary written language) as a patient in the oncology clinic independently. * Life expectancy greater than 3 months. * Patients must be able to provide written consent with the assistance of a professional interpreter. Exclusion Criteria: • Patients must be willing and able to complete the questionnaire independently without the assistance of others. Interpreter Questionnaires: Inclusion Criteria: * Interpreters must have provided medical interpretive services in a professional context for at least 3 months. * Interpreters must be willing and able to complete a questionnaire detailing their demographics and experiences working as a medical interpreter. * Interpreters must have experience providing medical interpretive services in an oncology or palliative care setting. Cancer Care Professional Questionnaires: Inclusion Criteria: * Physicians must be staff physicians, fellows, physician assistants, or residents in oncology or palliative care, who are experienced in providing medical care to CALD oncology patients in the context of gynecology or palliative care clinics. * Other cancer care professionals eligible to participate include but are not limited to nurses, clinical research coordinators, social workers, dietitians, pharmacists, psychologists, and administrative staff. * Cancer care professionals (except for administrative staff) must have had at least 3 months experience providing clinical care in an oncology or palliative care setting, and must have experience delivering care to CALD patients in this context. * Administrative staff must have at least 3 months experience working in the context of an oncology or palliative care clinic, and must have regular in-person or by phone patient contact. They must also have experience interacting with patients or carers from CALD backgrounds in an oncology/palliative care setting. * Cancer care professionals must be willing and able to complete a questionnaire independently detailing their demographics and experiences in treating CALD oncology or palliative care patients.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gynecologic cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Vitamin d gel on the scalp: a new hope against chemo hair loss?
- Can a personalized exercise program boost recovery in cancer survivors?
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- Braids and conditioner may boost scalp cooling against chemo hair loss
- New imaging tool could help surgeons detect hidden cancer cells during surgery
- Could an ALS drug clear the fog of chemo brain?